EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Platform for Integrative and Translational Biomedical Research

Pukar Khanal, Kunal Bhattacharya

Journal of Integrative and Translational Biomedicine · 2026

DOI: 10.67316/jintb.v1.i1.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative and Translational Biomedicine, 2026. Verfasst von Pukar Khanal und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomedical research and its outcomes are accelerated by integrating multiple disciplines, biological scales, and disease stages accessibility. Contemporary advances arise when molecular mechanisms are explored in tissue, systemic, and translational contexts (1, 2). Yet, despite this evolution, scholarly publishing and recognition largely remain fragmented, biased (3, 4), with integrative and translational studies struggling to find platforms that value conceptual synthesis alongside methodological rigor. The launch of Journal of Integrative and Translational Biomedicine (J. Integr. Transl. Biomed.) is intended to address this need. J. Integr. Transl. Biomed. (JINTB) supports research connecting missing dots of mechanistic insight with translational relevance. Here, integration is not merely combination of techniques, but deliberate link of biological processes across complex system. Translational research should be understood broadly, encompassing not only clinical application but also generation of frameworks that improve how disease initiation, progression, and therapeutic response are conceptualized. By bringing these dimensions together, JINTB aims to foster research to advance understanding in guiding future investigation. Scope of JINTB includes original research, opinion, review, methodological contributions, and integrative analyses, demonstrating biological mechanisms stimulating translational and forward-thinking. Studies bridging molecular, cellular, tissue, and system-level perspectives are highly encouraged as they include interdisciplinary efforts combining experimental, computational, and systems-based approaches. JINTB recognizes the value of rigorously designed confirmatory and negative studies if they refine hypotheses, challenge assumptions, or clarify inconsistencies in literature. A central motivation for JINTB is to provide space for question-driven, integrative thinking in complex disease biology, in cancer evolution, metabolic brain diseases, natural product research, and medicinal chemistry, thinking beyond classical disease targets, novel formulations, and therapeutic resistance. Key unresolved questions illustrate need for such approach. For example, how do early driver mutations interact with tissue-specific microenvironments to initiate clonal expansion? What distinguishes precancerous clones that progress to malignancy from those that remain indolent for decades? To what extent do factors, e.g., platelet-derived signaling or stromal activation, alter post-translational modification, neomorphic protein-protein interaction(s) reshape immune exclusion and resistance phenotypes, and through which cellular intermediaries do these effects operate? Addressing such questions requires integration across genetics, cell biology, immunology, biomechanics, and translational modeling, rather than single-domain analysis. JINTB encourages contributions that do not simply report observations but frame mechanistic findings in broader biological and translational narratives. The Core principle of JINTB is deference for scientific process. Peer review is intended to be fair, constructive, and focused on rigor, clarity, and relevance rather than on perceived novelty alone. Editorial decisions are guided by methodological soundness, ethical standards, and coherence with integrative and translational mission. Through this approach, JINTB aims to support the responsible dissemination of biomedical research. Ethical publishing practices form editorial standards. JINTB is committed to transparency in authorship, disclosure of conflicts of interest, data availability, and adherence to accepted norms of research integrity. Plagiarism, data fabrication, and inappropriate manipulation are not tolerated. At the same time, editors and reviewers are expected to engage with submissions professionally and respectfully, recognizing peer review as collaborative effort to strengthen scientific record. This inaugural issue marks the beginning of JINTB development and reflects long-term vision on quality, trust, and scholarly relevance. JINTB aims to evolve alongside advances in biomedical science, accommodating emerging paradigms and maintaining consistent editorial standards. Our goal is sustainable growth grounded in scientific value rather than rapid expansion. We invite researchers, reviewers, and readers to engage with JINTB by contributing their work, participating in peer review, and advancing constructive scientific dialogue. Through collective effort, JINTB aspires to be a reliable platform for integrative thinking and translational progress across biomedical sciences. We thank authors, reviewers, and editorial members whose contributions made this first issue possible. Their trust and commitment form foundation of JINTB. We look forward to continuing collaboration and to exchanging ideas in driving scientific progress.

Zitieren

APA

Khanal, P., & Bhattacharya, K. (2026). Platform for Integrative and Translational Biomedical Research. Journal of Integrative and Translational Biomedicine. https://doi.org/10.67316/jintb.v1.i1.8

Vancouver

Khanal P, Bhattacharya K. Platform for Integrative and Translational Biomedical Research. Journal of Integrative and Translational Biomedicine. 2026. doi:10.67316/jintb.v1.i1.8

BibTeX
@article{Khanal2026,
  author = {Khanal, Pukar and Bhattacharya, Kunal},
  title = {Platform for Integrative and Translational Biomedical Research},
  journal = {Journal of Integrative and Translational Biomedicine},
  year = {2026},
  doi = {10.67316/jintb.v1.i1.8}
}
Kostenlos starten →